Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorEster Ashraf Faried Beshay
About this trial
to detect the incidence of CTEPH patients.
Primary outcome To predict CETHP in symptomatic patients after pulmonary embolism episode.
Secondary outcome:
On Echocardiography revealed RV dysfunction which are peak TR Velocity , the RV/LV basal diameter ratio, flattening of the IVS, RV acceleration time and/or midsystolic notching, IVC diameter with decreased inspiratory collapse and RA area.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
All patients underwent pulmonary embolism episodes
Trial design
Design model
Cohort
Time perspective
Other
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Incidence of CTEHP in symptomatic patients after pulmonary embolism episode.
Incidence of CTEHP in symptomatic patients after pulmonary embolism episode.
Time frame
3 yearsSecondary outcomes
1
Measure of RV dysfunction by Echocardiography
Measure of RV dysfunction by Echocardiography
Time frame
3 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Ester Ashraf Faried Beshay
Lead sponsor
Assiut University
Sponsor institution
Source ClinicalTrials.gov